Glenmark Pharmaceuticals Limited has reported strong growth in the third quarter ended December 2015, despite the challenges in certain emerging markets, from where it sees "diminishing" contribution to revenues here on.
Glenmark reported a 48.38% jump in net profit to INR1.70bn ($24.9m) for the third quarter ended December 2015 led by...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?